442.45 +1.50 (0.34%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
429.0
Today’s High
444.35
52 Week Low
393.6
52 Week High
524.95
442.30 +5.90 (1.35%)
- 1D
- 5D
- 1M
- 6M
- 1Y
- 5Y
Price Range
Today’s Low
428.8
Today’s High
444.7
52 Week Low
393.4
52 Week High
524
Key Metrics
- Market Cap (In Cr) 19384.13
- Beta 1.09
- Div. Yield (%) 1.82
- P/B 9.33
- TTM P/E 26.8
- Peg Ratio -1.94
- Sector P/E 58.27
- D/E 0.04
- Open Price 432.3
- Prev Close 440.95
Analysis
Price Analysis
-
1 Week1.47%
-
3 Months-5.67%
-
6 Month-2.32%
-
YTD3.38%
-
1 Year-8.3%
Risk Meter
- 28% Low risk
- 28% Moderate risk
- 28% Balanced Risk
- 28% High risk
- 28% Extreme risk
Recos
27 Analysts
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- Strong Sell
- 0
- Sell
- 1
- Hold
- 4
- Buy
- 12
- Strong Buy
- 10
Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2022
- Total Revenue
- 3192.03
- Selling/ General/ Admin Expenses Total
- 1097.1
- Depreciation/ Amortization
- 333.64
- Other Operating Expenses Total
- 24.62
- Total Operating Expense
- 2573.68
- Operating Income
- 618.35
- Net Income Before Taxes
- 688
- Net Income
- 838.98
- Diluted Normalized EPS
- 18.94
- Period
- 2022
- Total Assets
- 3057.48
- Total Liabilities
- 980.89
- Total Equity
- 2076.59
- Tangible Book Valueper Share Common Eq
- 33.8
- Period
- 2022
- Cashfrom Operating Activities
- 643.92
- Cashfrom Investing Activities
- -234.9
- Cashfrom Financing Activities
- -402.14
- Net Changein Cash
- 7.76
- Period
- 2021
- Total Revenue
- 2880.53
- Selling/ General/ Admin Expenses Total
- 1005.84
- Depreciation/ Amortization
- 365.85
- Other Operating Expenses Total
- 23.43
- Total Operating Expense
- 2356.39
- Operating Income
- 524.13
- Net Income Before Taxes
- 568.92
- Net Income
- 454.7
- Diluted Normalized EPS
- 10.25
- Period
- 2021
- Total Assets
- 2519.69
- Total Liabilities
- 757.04
- Total Equity
- 1762.65
- Tangible Book Valueper Share Common Eq
- 31.69
- Period
- 2021
- Cashfrom Operating Activities
- 921.53
- Cashfrom Investing Activities
- -226.95
- Cashfrom Financing Activities
- -688.18
- Net Changein Cash
- 8.97
- Period
- 2020
- Total Revenue
- 2654.88
- Selling/ General/ Admin Expenses Total
- 1021.33
- Depreciation/ Amortization
- 335.23
- Other Operating Expenses Total
- 27.88
- Total Operating Expense
- 2301.36
- Operating Income
- 353.52
- Net Income Before Taxes
- 373.57
- Net Income
- 302.91
- Diluted Normalized EPS
- 6.77
- Period
- 2020
- Total Assets
- 2678.48
- Total Liabilities
- 854.73
- Total Equity
- 1823.75
- Tangible Book Valueper Share Common Eq
- 26.56
- Period
- 2020
- Cashfrom Operating Activities
- 530.75
- Cashfrom Investing Activities
- -227.69
- Cashfrom Financing Activities
- -405.36
- Net Changein Cash
- -105.63
- Period
- 2019
- Total Revenue
- 2692.94
- Selling/ General/ Admin Expenses Total
- 984.17
- Depreciation/ Amortization
- 322.63
- Other Operating Expenses Total
- 25.92
- Total Operating Expense
- 2296.08
- Operating Income
- 396.86
- Net Income Before Taxes
- 403.41
- Net Income
- 303.23
- Diluted Normalized EPS
- 6.84
- Period
- 2019
- Total Assets
- 2822.37
- Total Liabilities
- 746.3
- Total Equity
- 2076.06
- Tangible Book Valueper Share Common Eq
- 26.41
- Period
- 2019
- Cashfrom Operating Activities
- 553.74
- Cashfrom Investing Activities
- -23.39
- Cashfrom Financing Activities
- -427.66
- Net Changein Cash
- 100.28
- Period
- 2018
- Total Revenue
- 2540.83
- Selling/ General/ Admin Expenses Total
- 943.63
- Depreciation/ Amortization
- 309.6
- Other Operating Expenses Total
- 29.2
- Total Operating Expense
- 2126.64
- Operating Income
- 414.19
- Net Income Before Taxes
- 393.77
- Net Income
- 307.14
- Diluted Normalized EPS
- 6.77
- Period
- 2018
- Total Assets
- 2800.74
- Total Liabilities
- 787.13
- Total Equity
- 2013.61
- Tangible Book Valueper Share Common Eq
- 22.12
- Period
- 2018
- Cashfrom Operating Activities
- 587.81
- Cashfrom Investing Activities
- -279.12
- Cashfrom Financing Activities
- -323.74
- Net Changein Cash
- -12.21
- Period
- 2017
- Total Revenue
- 2527.74
- Selling/ General/ Admin Expenses Total
- 886.95
- Depreciation/ Amortization
- 307.44
- Other Operating Expenses Total
- 27.54
- Total Operating Expense
- 2072.37
- Operating Income
- 455.37
- Net Income Before Taxes
- 423.62
- Net Income
- 340.42
- Diluted Normalized EPS
- 7.47
- Period
- 2017
- Total Assets
- 2603.16
- Total Liabilities
- 848.47
- Total Equity
- 1754.69
- Tangible Book Valueper Share Common Eq
- 11.07
- Period
- 2017
- Cashfrom Operating Activities
- 729.62
- Cashfrom Investing Activities
- -297.48
- Cashfrom Financing Activities
- -495.82
- Net Changein Cash
- -72.11
- Period
- 2022-09-30
- Total Revenue
- 813.75
- Selling/ General/ Admin Expenses Total
- 234.95
- Depreciation/ Amortization
- 47.93
- Other Operating Expenses Total
- 111.85
- Total Operating Expense
- 666.3
- Operating Income
- 147.45
- Net Income Before Taxes
- 185.52
- Net Income
- 184.18
- Diluted Normalized EPS
- 4.17
- Period
- 2022-09-30
- Total Assets
- 3173.44
- Total Liabilities
- 840.86
- Total Equity
- 2332.58
- Tangible Book Valueper Share Common Eq
- 39.15
- Period
- 2022-09-30
- Cashfrom Operating Activities
- 278.25
- Cashfrom Investing Activities
- -72.44
- Cashfrom Financing Activities
- -193.81
- Net Changein Cash
- 10.15
- Period
- 2022-06-30
- Total Revenue
- 773.31
- Selling/ General/ Admin Expenses Total
- 225.09
- Depreciation/ Amortization
- 88.11
- Other Operating Expenses Total
- 88.81
- Total Operating Expense
- 688.1
- Operating Income
- 85.21
- Net Income Before Taxes
- 84.68
- Net Income
- 73.83
- Diluted Normalized EPS
- 1.67
- Period
- 2022-06-30
- Period
- 2022-06-30
- Period
- 2022-03-31
- Total Revenue
- 770.39
- Selling/ General/ Admin Expenses Total
- 228.33
- Depreciation/ Amortization
- 83.46
- Other Operating Expenses Total
- 88.23
- Total Operating Expense
- 695.09
- Operating Income
- 75.3
- Net Income Before Taxes
- 97.84
- Net Income
- 355.96
- Diluted Normalized EPS
- 8.12
- Period
- 2022-03-31
- Total Assets
- 3057.48
- Total Liabilities
- 980.89
- Total Equity
- 2076.59
- Tangible Book Valueper Share Common Eq
- 33.8
- Period
- 2022-03-31
- Cashfrom Operating Activities
- 643.92
- Cashfrom Investing Activities
- -234.9
- Cashfrom Financing Activities
- -402.14
- Net Changein Cash
- 7.76
- Period
- 2021-12-31
- Total Revenue
- 971.85
- Selling/ General/ Admin Expenses Total
- 230.6
- Depreciation/ Amortization
- 84.44
- Other Operating Expenses Total
- 82.72
- Total Operating Expense
- 714.75
- Operating Income
- 257.1
- Net Income Before Taxes
- 268.61
- Net Income
- 219.97
- Diluted Normalized EPS
- 4.94
- Period
- 2021-12-31
- Period
- 2021-12-31
- Period
- 2021-09-30
- Total Revenue
- 787.12
- Selling/ General/ Admin Expenses Total
- 187.39
- Depreciation/ Amortization
- 83.88
- Other Operating Expenses Total
- 77.89
- Total Operating Expense
- 593.82
- Operating Income
- 193.3
- Net Income Before Taxes
- 226.29
- Net Income
- 185.27
- Diluted Normalized EPS
- 4.17
- Period
- 2021-09-30
- Total Assets
- 2835.14
- Total Liabilities
- 775.3
- Total Equity
- 2059.84
- Tangible Book Valueper Share Common Eq
- 41.06
- Period
- 2021-09-30
- Cashfrom Operating Activities
- 290.84
- Cashfrom Investing Activities
- -301.62
- Cashfrom Financing Activities
- 24.04
- Net Changein Cash
- 13.11
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Technical
Moving Average
SMA
- 5 Day424.34
- 10 Day428.18
- 20 Day426.77
- 50 Day434.03
- 100 Day459.42
- 300 Day455.58
Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- P & G Hygiene & Health Care
- 13789.25
- 33.05
- 0.24
- 16466.4
- 12751
- 44032.99
- Colgate Palmolive India
- 1447.5
- -2.35
- -0.16
- 1695
- 1387.3
- 39353.6
- Emami
- 442.45
- 1.5
- 0.34
- 524.95
- 393.6
- 19384.13
- Gillette India
- 4880
- -11.95
- -0.24
- 5700.5
- 4751
- 15868.84
- Indiamart Intermesh
- 4490
- 78.05
- 1.77
- 5379.9
- 3676.05
- 13555.63
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- P & G Hygiene & Health Care
- 75.48
- 59.7
- 58.18
- 15.46
- Colgate Palmolive India
- 36.49
- 22.69
- 60.52
- 18.83
- Emami
- 23.2
- 9.33
- 23.01
- 15.78
- Gillette India
- 52.73
- 18.43
- 34.04
- 13.83
- Indiamart Intermesh
- 45.83
- 7.23
- 34.13
- 28.25
Shareholding
- Category
- Percentage
- No. of shares
- Public Shareholding
- 45.73%
- 201,756,588
- DSP DYNAMIC ASSET ALLOCATION FUND
- 5.65%
- 24,939,376
- MIRAE ASSET BALANCED ADVANTAGE FUND
- 4.19%
- 18,482,432
- HDFC LARGE AND MID CAP FUND
- 2.98%
- 13,130,715
- HSBC FLEXI CAP FUND
- 2.14%
- 9,457,079
- KOTAK DEBT HYBRID
- 1.78%
- 7,837,951
- ADITYA BIRLA SUN LIFE TRUSTEE PRIVATE LIMITED A/C ADITYA BIRLA SUN LIFE NIFTY M
- 1.69%
- 7,443,441
- FRANKLIN INDIA FOCUSED EQUITY FUND
- 1.58%
- 6,951,225
- NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA CAPITAL BUILDER FUND IV - SERIES
- 1.28%
- 5,644,983
- Others
- 2.28%
- 10,087,650
- Others
- 10.72%
- 47,306,767
- Others
- 3.69%
- 16,261,477
- HDFC LIFE INSURANCE COMPANY LIMITED
- 1.97%
- 8,669,452
- Others
- 1.41%
- 6,248,422
- AVEES TRADING AND FINANCE PVT LTD
- 2.1%
- 9,285,353
- Others
- 1.04%
- 4,592,046
- Others
- 0.42%
- 1,863,463
- Others
- 0.3%
- 1,316,651
- Others
- 0.17%
- 752,614
- HUF
- 0.13%
- 573,086
- Clearing Members
- 0.02%
- 108,924
- Unclaimed or Suspense or Escrow Account
- 0.01%
- 30,574
- Trusts
- 0%
- 6,065
- Others
- 0.09%
- 375,341
- Others
- 0.05%
- 235,398
- Others
- 0.02%
- 86,338
- Others
- 0.02%
- 69,576
- Others
- 0%
- 189
- Promoter & Promoter Group Shareholding
- 54.27%
- 239,393,412
- SURAJ FINVEST PRIVATE LIMITED
- 23.96%
- 105,720,226
- SNEHA ENCLAVE PRIVATE LIMITED
- 22.37%
- 98,667,956
- MIDKOT INVESTMENTS PRIVATE LIMITED
- 0.71%
- 3,117,160
- EMAMI PAPER MILLS LTD
- 0.21%
- 933,000
- EMAMI FRANK ROSS LIMITED
- 0%
- 10,000
- PRITI A SUREKA
- 3.42%
- 15,104,702
- AVISHI SUREKA
- 0.32%
- 1,400,000
- SACHIN GOENKA
- 0.16%
- 717,000
- SHOBHANA AGARWAL
- 0.14%
- 630,000
- SASWAT GOENKA
- 0.13%
- 580,000
- VIBHASH VARDHAN AGARWAL
- 0.13%
- 573,478
- DARSH GOENKA
- 0.13%
- 565,000
- MANAN GOENKA
- 0.13%
- 565,000
- ADVAY GOENKA
- 0.13%
- 554,000
- JYOTI AGARWAL
- 0.11%
- 488,000
- REYANSH GOENKA
- 0.09%
- 407,750
- DEVARSH GOENKA
- 0.09%
- 407,750
- RADHESHYAM GOENKA
- 0.09%
- 400,876
- CHIKKY GOENKA
- 0.08%
- 371,700
- RACHANA GOENKA
- 0.07%
- 317,700
- RAJKUMAR GOENKA
- 0.07%
- 302,364
- SMRITI AGARWAL
- 0.07%
- 299,000
- RACHNA BAGARIA
- 0.06%
- 270,000
- INDU GOENKA
- 0.06%
- 269,700
- NIMISHA GOENKA
- 0.06%
- 244,000
- REHA GOENKA
- 0.05%
- 240,000
- SHREYA GOENKA
- 0.05%
- 230,000
- SAROJ GOENKA
- 0.05%
- 215,240
- ADITYA VARDHAN AGARWAL HUF
- 0.05%
- 204,278
- SHRUTI GOENKA
- 0.04%
- 196,130
- RADHESHYAM AGARWAL
- 0.04%
- 195,000
- PRASHANT GOENKA
- 0.04%
- 190,000
- MOHAN GOENKA HUF
- 0.04%
- 174,000
- MANISH GOENKA HUF
- 0.04%
- 174,000
- SUSHIL KUMAR GOENKA HUF
- 0.04%
- 174,000
- USHA AGARWAL
- 0.04%
- 173,096
- HARSHA VARDHAN AGARWAL HUF
- 0.04%
- 172,000
- VIHAN VARDHAN AGARWAL
- 0.04%
- 172,000
- ASHISH GOENKA
- 0.04%
- 169,400
- PUJA GOENKA
- 0.04%
- 169,398
- JAYANT GOENKA
- 0.04%
- 156,254
- MANSI AGARWAL
- 0.03%
- 150,000
- MANISH GOENKA
- 0.03%
- 142,196
- ADITYA VARDHAN AGARWAL
- 0.03%
- 134,668
- RASHMI GOENKA
- 0.03%
- 121,400
- LAXMI DEVI BAJORIA
- 0.03%
- 121,000
- SANTOSH GOENKA
- 0.03%
- 115,640
- SUSHIL KUMAR GOENKA
- 0.03%
- 114,300
- HARSHA VARDHAN AGARWAL
- 0.02%
- 110,266
- RICHA AGARWAL
- 0.02%
- 93,222
- VIDHISHREE AGARWAL
- 0.02%
- 80,000
- VIDULA AGARWAL
- 0.02%
- 80,000
- PRASHANT GOENKA HUF
- 0.02%
- 74,000
- ASHISH GOENKA HUF
- 0.02%
- 74,000
- JAYANT GOENKA HUF
- 0.02%
- 74,000
- MOHAN GOENKA
- 0.01%
- 61,900
- MADAN LAL AGARWAL
- 0.01%
- 60,000
- JYOTI GOENKA
- 0.01%
- 48,776
- KUSUM AGARWAL
- 0.01%
- 36,300
- PRADIP KUMAR AGARWAL
- 0.01%
- 31,150
- DIVYA AGARWAL
- 0.01%
- 26,000
- SANGITA AGARWAL
- 0.01%
- 26,000
- SHUBHAM AGARWAL
- 0.01%
- 24,460
- ABHISHEK AGARWAL
- 0.01%
- 24,000
- DHIRAJ AGARWAL
- 0%
- 16,750
- SUMANGAL AGARWAL
- 0%
- 8,200
- VISHAL AGARWAL
- 0%
- 8,200
- ROHIN RAJ SUREKA
- 0%
- 5,000
- Amitabh Goenka
- 0.13%
- 571,496
- RITU GOENKA
- 0.1%
- 454,930
- NIKUNJ GOENKA
- 0.06%
- 265,000
- YOGESH GOENKA
- 0.06%
- 245,400
- AMITABH GOENKA HUF
- 0.02%
- 74,000
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 03-Feb-23
- Quarterly Results & 2nd Interim Dividend
- 11-Nov-22
- Quarterly Results & Interim Dividend
- 29-Jul-22
- Quarterly Results
- 13-May-22
- Audited Results
- 03-Feb-22
- Qty Results, Int. Dividend & Buy Back
- 29-Oct-21
- Quarterly Results & Interim Dividend
- 02-Aug-21
- Quarterly Results
- 25-May-21
- Audited Results
- 27-Jan-21
- Quarterly Results & Interim Dividend
- Meeting Date
- Announced on
- Purpose
- 28-Jun-22
- 25-May-22
- POM
- 29-Mar-22
- 24-Feb-22
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 18-Oct-22
- 21-Nov-22
- 18-Nov-22
- 4
- 17-Jan-22
- 11-Feb-22
- 10-Feb-22
- 4
- 18-Oct-21
- 09-Nov-21
- 08-Nov-21
- 4
- 18-Jan-21
- 05-Feb-21
- 04-Feb-21
- 4
No recent bonus announcements.
No recent splits available.
No recent rights issue declared.
Company Profile
ABOUT Emami
- Industry Personal & Household Prods.
- ISIN INE548C01032
- BSE Code 531162
- NSE Code EMAMILTD
Emami Limited is an India-based fast-moving consumer goods company (FMCG). The Company is engaged in the business of manufacturing and marketing personal care, healthcare and beauty products. The Company's product categories include cooling oils, balms, antiseptic cream, fairness creams for men and ayurvedic hair and scalp care oils. Its portfolio comprises of approximately 300 products. The Company's brand names include Boro Plus, Navratna, Fair and Handsome, Zandu Balm, Navratna, Kesh King, Zandu Pancharishta, fast relief, 7oils in one, Diamond shine, Emami golden beauty, Emami naturally fair, Emami Emasol, Creme21, Mentho Plus Balm, Dermicool and others. It also provides BoroPlus Organic Aloe Vera Gel, BoroPlus Hygiene range, EMASOL Home Hygiene range and various healthcare products under Zandu. Its subsidiaries include Emami Bangladesh Ltd., Emami International FZE, Emami Indo Lanka Pvt. Ltd, Emami Overseas FZE, Emami Rus LLC, Creme 21 GmbH and Pharmaderm Company SAE.
MANAGEMENT
- Harsha Agarwal Vice Chairman of the Board, Managing Director
- Mohan Goenka Vice Chairman of the Board, Whole Time Director
- Naresh Bhansali Chief Financial Officer, Chief Executive Officer - Finance, Strategy and Business Development
- Gul Bhatia President - Health Care Division
- Vivek Dhir Chief Executive Officer- International Business
- Punita Kalra Chief Executive Officer - Research and Innovation Strategy and Corporate Quality Assurance, CADE
- C. K. Katiyar Chief Executive Officer - Technical, Health Care
- Sanjay Madan President - Operations
- Pradeep Pandey President - Packaging
- Vinod Rao President - Sales, Consumer Care Division
Company Summary
EMAMI SUMMARY
Emami is trading 0.34% upper at Rs 442.45 as compared to its last closing price. Emami has been trading in the price range of 444.35 & 429.0. Emami has given 3.38% in this year & 1.47% in the last 5 days.
Emami has TTM P/E ratio 26.8 as compared to the sector P/E of 58.27. There are 27 analysts who have initiated coverage on Emami. There are 10 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.
The company posted a net profit of 184.18 Crores in its last quarter.
Listed peers of Emami include P & G Hygiene & Health Care (0.24%), Colgate Palmolive India (-0.16%), Emami (0.34%) etc.
Emami has a 54.27% promoter holding & 45.73% public holding.
FAQs about Emami
Emami is trading at 442.45 as on 31 Jan, 2023 12:12:26 PM. This is 0.34% upper as compared to its previous closing price of 440.95
The market capitalization of Emami is 19384.13 Cr as on 31 Jan, 2023 12:12:26 PM.
The average broker rating on Emami is Buy. The breakup of analyst rating is given below -
- 0 analysts have given a strong sell rating
- 1 analysts have given a sell rating
- 4 analysts have given a hold rating
- 12 analysts have given a buy rating
- 10 analysts have given a strong buy rating
The 52 wk high for Emami is 524.95 whereas the 52 wk low is 393.6
Emami can be analyzed on the following key metrics -
- TTM P/E: 26.8
- Sector P/E: 58.27
- Dividend Yield: 1.82%
- D/E ratio: -
Emami reported a net profit of 838.98 Cr in 2022.
